Legal & General Group’s Neumora Therapeutics NMRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,500
| Closed | -$10.5K | – | 3493 |
|
|
2025
Q1 | $10.5K | Sell |
10,500
-49,342
| -82% | -$49.3K | ﹤0.01% | 3161 |
|
|
2024
Q4 | $634K | Buy |
59,842
+50,289
| +526% | +$533K | ﹤0.01% | 2376 |
|
|
2024
Q3 | $126K | Buy |
9,553
+249
| +3% | +$3.29K | ﹤0.01% | 2715 |
|
|
2024
Q2 | $91.4K | Buy |
9,304
+7,882
| +554% | +$77.4K | ﹤0.01% | 2734 |
|
|
2024
Q1 | $19.5K | Hold |
1,422
| – | – | ﹤0.01% | 2971 |
|
|
2023
Q4 | $24.2K | Sell |
1,422
-8,578
| -86% | -$146K | ﹤0.01% | 2955 |
|
|
2023
Q3 | $140K | Buy |
+10,000
| New | +$140K | ﹤0.01% | 2786 |
|